{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:39Z","timestamp":1792787919183,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Hunan Provincial Natural Science Foundation","award":["2022JJ70032"],"award-info":[{"award-number":["2022JJ70032"]}]},{"name":"the Hunan Provincial Natural Science Foundation","award":["2024JJ6623"],"award-info":[{"award-number":["2024JJ6623"]}]},{"name":"the Hunan Provincial Natural Science Foundation","award":["2025JJ80826"],"award-info":[{"award-number":["2025JJ80826"]}]},{"name":"the Hunan Provincial Natural Science Foundation","award":["2025JJ80863"],"award-info":[{"award-number":["2025JJ80863"]}]},{"name":"the Hunan Provincial Natural Science Foundation","award":["2025JJ80840"],"award-info":[{"award-number":["2025JJ80840"]}]},{"name":"the Hunan Provincial Natural Science Foundation","award":["2025JJ50487"],"award-info":[{"award-number":["2025JJ50487"]}]},{"name":"the High-Level Talent Support Program of Hunan Cancer Hospital","award":["20250805-1006"],"award-info":[{"award-number":["20250805-1006"]}],"id":[{"id":"https:\/\/ror.org\/025020z88","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the High-Level Talent Support Program of Hunan Cancer Hospital","award":["20250731-1024"],"award-info":[{"award-number":["20250731-1024"]}],"id":[{"id":"https:\/\/ror.org\/025020z88","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Hunan Cancer Hospital Climb Plan","award":["Grant No. QH2023004"],"award-info":[{"award-number":["Grant No. QH2023004"]}],"id":[{"id":"https:\/\/ror.org\/025020z88","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Natural Sciences Foundation of China","award":["82273219"],"award-info":[{"award-number":["82273219"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04406-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:58:39Z","timestamp":1782845919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47\/SIRP\u03b1 axis"],"prefix":"10.1186","volume":"26","author":[{"given":"Siyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengqiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"4406_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4406_CR2","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"WJ Yang","year":"2023","unstructured":"Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29:2452\u201368. https:\/\/doi.org\/10.3748\/wjg.v29.i16.2452.","journal-title":"World J Gastroenterol"},{"key":"4406_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41419-024-06875-4","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Dong Y, Yu S, Hu K, Zhang L, Xiong M, Liu M, Sun X, Li S, Yuan Y, et al. IL-4\/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcgamma receptor IIB in M2 macrophages. Cell Death Dis. 2024;15:500. https:\/\/doi.org\/10.1038\/s41419-024-06875-4.","journal-title":"Cell Death Dis"},{"key":"4406_CR4","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/neuonc\/noac063","volume":"24","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Meng X, He W, Li X, Zhao R, Dong C, Yuan D, Yang J, Zhang R, Shi G, et al. USF1\/CD90 signaling in maintaining glioblastoma stem cells and tumor-associated macrophages adhesion. Neuro Oncol. 2022;24:1482\u201393. https:\/\/doi.org\/10.1093\/neuonc\/noac063.","journal-title":"Neuro Oncol"},{"key":"4406_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10020-023-00616-7","volume":"29","author":"F Zeng","year":"2023","unstructured":"Zeng F, Gao M, Liao S, Zhou Z, Luo G, Zhou Y. Role and mechanism of CD90(+) fibroblasts in inflammatory diseases and malignant tumors. Mol Med. 2023;29:20. https:\/\/doi.org\/10.1186\/s10020-023-00616-7.","journal-title":"Mol Med"},{"key":"4406_CR6","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1309\/AJCPM2Z4NGIIPBGE","volume":"140","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Hiroshima K, Suzuki T, Chai K, Yamaguchi N, Shingyoji M, Yusa T, Tada Y, Takiguchi Y, Tatsumi K, et al. CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry. Am J Clin Pathol. 2013;140:544\u20139. https:\/\/doi.org\/10.1309\/AJCPM2Z4NGIIPBGE.","journal-title":"Am J Clin Pathol"},{"key":"4406_CR7","doi-asserted-by":"publisher","first-page":"11611","DOI":"10.1007\/s13277-016-5112-0","volume":"37","author":"A Kumar","year":"2016","unstructured":"Kumar A, Bhanja A, Bhattacharyya J, Jaganathan BG. Multiple roles of CD90 in cancer. Tumour Biol. 2016;37:11611\u201322. https:\/\/doi.org\/10.1007\/s13277-016-5112-0.","journal-title":"Tumour Biol"},{"key":"4406_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/ol.2021.12451","volume":"21","author":"L Gao","year":"2021","unstructured":"Gao L, Li J, He J, Liang L, He Z, Yue C, Jin X, Luo G, Zhou Y. CD90 affects the biological behavior and energy metabolism level of gastric cancer cells by targeting the PI3K\/AKT\/HIF-1alpha signaling pathway. Oncol Lett. 2021;21:191. https:\/\/doi.org\/10.3892\/ol.2021.12451.","journal-title":"Oncol Lett"},{"key":"4406_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/jso.25192","volume":"118","author":"R Yamaoka","year":"2018","unstructured":"Yamaoka R, Ishii T, Kawai T, Yasuchika K, Miyauchi Y, Kojima H, Katayama H, Ogiso S, Fukumitsu K, Uemoto S. CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis. J Surg Oncol. 2018;118:664\u201374. https:\/\/doi.org\/10.1002\/jso.25192.","journal-title":"J Surg Oncol"},{"key":"4406_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13048-019-0590-5","volume":"12","author":"EV Connor","year":"2019","unstructured":"Connor EV, Saygin C, Braley C, Wiechert AC, Karunanithi S, Crean-Tate K, Abdul-Karim FW, Michener CM, Rose PG, Lathia JD, Reizes O. Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer. J Ovarian Res. 2019;12:112. https:\/\/doi.org\/10.1186\/s13048-019-0590-5.","journal-title":"J Ovarian Res"},{"key":"4406_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/neup.12244","volume":"36","author":"A Inoue","year":"2016","unstructured":"Inoue A, Tanaka J, Takahashi H, Kohno S, Ohue S, Umakoshi A, Gotoh K, Ohnishi T. Blood vessels expressing CD90 in human and rat brain tumors. Neuropathology. 2016;36:168\u201380. https:\/\/doi.org\/10.1111\/neup.12244.","journal-title":"Neuropathology"},{"key":"4406_CR12","first-page":"45","volume":"7","author":"B Moazen","year":"2018","unstructured":"Moazen B, Zarrinhaghighi A, Nejatollahi F. Selection and Evaluation of Specific Single Chain Antibodies against CD90, a Marker for Mesenchymal and Cancer Stem Cells. Rep Biochem Mol Biol. 2018;7:45\u201351.","journal-title":"Rep Biochem Mol Biol"},{"key":"4406_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1158\/2326-6066.CIR-14-0120","volume":"3","author":"M Moskalenko","year":"2015","unstructured":"Moskalenko M, Pan M, Fu Y, de Moll EH, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Bernardo S, Sikora AG, et al. Requirement for innate immunity and CD90(+) NK1.1(-) lymphocytes to treat established melanoma with chemo-immunotherapy. Cancer Immunol Res. 2015;3:296\u2013304. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0120.","journal-title":"Cancer Immunol Res"},{"key":"4406_CR14","doi-asserted-by":"publisher","first-page":"e1584","DOI":"10.1002\/ctm2.1584","volume":"14","author":"JS Isenberg","year":"2024","unstructured":"Isenberg JS, Montero E. Tolerating CD47. Clin Transl Med. 2024;14:e1584. https:\/\/doi.org\/10.1002\/ctm2.1584.","journal-title":"Clin Transl Med"},{"key":"4406_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86\u201390. https:\/\/doi.org\/10.1038\/nature18935.","journal-title":"Nature"},{"key":"4406_CR16","doi-asserted-by":"publisher","unstructured":"Osorio JC, Smith P, Knorr DA, Ravetch JV. 2023. The antitumor activities of anti-CD47 antibodies require Fc-FcgammaR interactions. Cancer Cell. 41, 2051\u20132065 e2056. https:\/\/doi.org\/10.1016\/j.ccell.2023.10.007","DOI":"10.1016\/j.ccell.2023.10.007"},{"key":"4406_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRPalpha Immune Checkpoint. Immunity. 2020;52:742\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.011.","journal-title":"Immunity"},{"key":"4406_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","volume":"32","author":"AN Barclay","year":"2014","unstructured":"Barclay AN, Van den Berg TK. The interaction between signal regulatory protein alpha (SIRPalpha) and CD47: structure, function, and therapeutic target. Annu Rev Immunol. 2014;32:25\u201350. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120142.","journal-title":"Annu Rev Immunol"},{"key":"4406_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138:271\u201385. https:\/\/doi.org\/10.1016\/j.cell.2009.05.046.","journal-title":"Cell"},{"key":"4406_CR20","doi-asserted-by":"publisher","first-page":"18342","DOI":"10.1073\/pnas.1106550108","volume":"108","author":"XW Zhao","year":"2011","unstructured":"Zhao XW, van Beek EM, Schornagel K, Van der Maaden H, Van Houdt M, Otten MA, Finetti P, Van Egmond M, Matozaki T, Kraal G, et al. CD47-signal regulatory protein-alpha (SIRPalpha) interactions form a barrier for antibody-mediated tumor cell destruction. Proc Natl Acad Sci U S A. 2011;108:18342\u20137. https:\/\/doi.org\/10.1073\/pnas.1106550108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4406_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature22076","volume":"544","author":"J Chen","year":"2017","unstructured":"Chen J, Zhong MC, Guo H, Davidson D, Mishel S, Lu Y, Rhee I, Perez-Quintero LA, Zhang S, Cruz-Munoz ME, et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature. 2017;544:493\u20137. https:\/\/doi.org\/10.1038\/nature22076.","journal-title":"Nature"},{"key":"4406_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.20517\/cdr.2024.101","volume":"7","author":"F Zeng","year":"2024","unstructured":"Zeng F, Cao J, Chen Y, Tang J, He Q, Liao S, Liang L, Li W, Liu S, Luo G, Zhou Y. Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells. Cancer Drug Resist. 2024;7:44. https:\/\/doi.org\/10.20517\/cdr.2024.101.","journal-title":"Cancer Drug Resist"},{"key":"4406_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3892\/ijo.2018.4651","volume":"54","author":"YS Ge","year":"2019","unstructured":"Ge YS, Long YH, Xiao SS, Liang L, He ZX, Yue CX, Wei X, Zhou YH. CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells. Int J Oncol. 2019;54:585\u201399. https:\/\/doi.org\/10.3892\/ijo.2018.4651.","journal-title":"Int J Oncol"},{"key":"4406_CR24","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/eji.201343592","volume":"44","author":"PMM Moraes-Vieira","year":"2014","unstructured":"Moraes-Vieira PMM, Larocca RA, Bassi EJ, Peron JPS, Andrade-Oliveira V, Wasinski F, Araujo R, Thornley T, Quintana FJ, Basso AS, et al. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells. Eur J Immunol. 2014;44:794\u2013806. https:\/\/doi.org\/10.1002\/eji.201343592.","journal-title":"Eur J Immunol"},{"key":"4406_CR25","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.7150\/ijbs.60782","volume":"17","author":"X Jia","year":"2021","unstructured":"Jia X, Yan B, Tian X, Liu Q, Jin J, Shi J, Hou Y. CD47\/SIRPalpha pathway mediates cancer immune escape and immunotherapy. Int J Biol Sci. 2021;17:3281\u20137. https:\/\/doi.org\/10.7150\/ijbs.60782.","journal-title":"Int J Biol Sci"},{"key":"4406_CR26","doi-asserted-by":"publisher","first-page":"e2303835","DOI":"10.1002\/adma.202303835","volume":"35","author":"L Tang","year":"2023","unstructured":"Tang L, Yin Y, Cao Y, Fu C, Liu H, Feng J, Wang W, Liang XJ. Extracellular Vesicles-Derived Hybrid Nanoplatforms for Amplified CD47 Blockade-Based Cancer Immunotherapy. Adv Mater. 2023;35:e2303835. https:\/\/doi.org\/10.1002\/adma.202303835.","journal-title":"Adv Mater"},{"key":"4406_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye JQ, Connolly AJ, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86\u2013. https:\/\/doi.org\/10.1038\/nature18935.","journal-title":"Nature"},{"key":"4406_CR28","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1158\/0008-5472.Can-23-0783","volume":"83","author":"YB Fan","year":"2023","unstructured":"Fan YB, Song SM, Li Y, Dhar SS, Jin JK, Yoshimura K, Yao XD, Wang RP, Scott AW, Pizzi MP, et al. Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res. 2023;83:3726\u201338. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0783.","journal-title":"Cancer Res"},{"key":"4406_CR29","doi-asserted-by":"crossref","unstructured":"Yu L, Ding Y, Wan T, Deng T, Huang H, Liu JH. 2021. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer. Frontiers in Immunology.","DOI":"10.3389\/fimmu.2021.768115"},{"key":"4406_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2019.03.051","volume":"453","author":"J Shi","year":"2019","unstructured":"Shi J, Lu P, Shen W, He R, Yang MW, Fang Y, Sun YW, Niu N, Xue J. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer. Cancer Lett. 2019;453:158\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.051.","journal-title":"Cancer Lett"},{"key":"4406_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-022-02283-8","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Gigante I, Cigliano A, Ribback S, Sanese P, Grossi V, Simone C, Armentano R, Evert M, et al. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. J Exp Clin Cancer Res. 2022;41:65. https:\/\/doi.org\/10.1186\/s13046-022-02283-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"4406_CR32","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, Zhou K, Li W, Hu J, Fu C, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40:1566\u2013e15821510. https:\/\/doi.org\/10.1016\/j.ccell.2022.10.004.","journal-title":"Cancer Cell"},{"key":"4406_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","volume":"22","author":"H Fang","year":"2023","unstructured":"Fang H, Sun Q, Zhou J, Zhang H, Song Q, Zhang H, Yu G, Guo Y, Huang C, Mou Y, et al. m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023;22:99. https:\/\/doi.org\/10.1186\/s12943-023-01791-1.","journal-title":"Mol Cancer"},{"key":"4406_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41419-024-06509-9","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Yan J, Huang H, Liu L, Ren L, Hu J, Jiang X, Zheng Y, Xu L, Zhong F, Li X. The m(6)A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis. Cell Death Dis. 2024;15:189. https:\/\/doi.org\/10.1038\/s41419-024-06509-9.","journal-title":"Cell Death Dis"},{"key":"4406_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, Chen ZH, Zeng ZL, Wang F, Zheng J, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18:112. https:\/\/doi.org\/10.1186\/s12943-019-1038-7.","journal-title":"Mol Cancer"},{"key":"4406_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41419-021-03571-5","volume":"12","author":"H Shen","year":"2021","unstructured":"Shen H, Zhu H, Chen Y, Shen Z, Qiu W, Qian C, Zhang J. ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression. Cell Death Dis. 2021;12:349. https:\/\/doi.org\/10.1038\/s41419-021-03571-5.","journal-title":"Cell Death Dis"},{"key":"4406_CR37","doi-asserted-by":"publisher","unstructured":"Ouyang J, Li J, Li D, Jiang J, Hao T, Xia Y, Lu X, Zhang C, He Y. 2022. IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer. Cancers (Basel). 14, https:\/\/doi.org\/10.3390\/cancers14215381","DOI":"10.3390\/cancers14215381"},{"key":"4406_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13062-023-00373-x","volume":"18","author":"TY Liu","year":"2023","unstructured":"Liu TY, Hu CC, Han CY, Mao SY, Zhang WX, Xu YM, Sun YJ, Jiang DB, Zhang XY, Zhang JX, et al. IGF2BP2 promotes colorectal cancer progression by upregulating the expression of TFRC and enhancing iron metabolism. Biol Direct. 2023;18:19. https:\/\/doi.org\/10.1186\/s13062-023-00373-x.","journal-title":"Biol Direct"},{"key":"4406_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-022-01608-7","volume":"21","author":"B Yao","year":"2022","unstructured":"Yao B, Zhang Q, Yang Z, An F, Nie H, Wang H, Yang C, Sun J, Chen K, Zhou J, et al. CircEZH2\/miR-133b\/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA. Mol Cancer. 2022;21:140. https:\/\/doi.org\/10.1186\/s12943-022-01608-7.","journal-title":"Mol Cancer"},{"key":"4406_CR40","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12967-024-05498-9","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, Fei Y, Zuo X, Cai J. CircRHBDD1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22:704. https:\/\/doi.org\/10.1186\/s12967-024-05498-9.","journal-title":"J Transl Med"},{"key":"4406_CR41","doi-asserted-by":"publisher","first-page":"100886","DOI":"10.1016\/j.drup.2022.100886","volume":"65","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zheng N, Li J, Li C, Zheng D, Jiang X, Ge X, Liu M, Liu L, Song Z, et al. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells. Drug Resist Updat. 2022;65:100886. https:\/\/doi.org\/10.1016\/j.drup.2022.100886.","journal-title":"Drug Resist Updat"},{"key":"4406_CR42","doi-asserted-by":"publisher","first-page":"155436","DOI":"10.1016\/j.phymed.2024.155436","volume":"126","author":"X Liu","year":"2024","unstructured":"Liu X, Xiong H, Lu M, Liu B, Hu C, Liu P. Trans-3, 5, 4\u2019-trimethoxystilbene restrains non-small-cell lung carcinoma progression via suppressing M2 polarization through inhibition of m6A modified circPACRGL-mediated Hippo signaling. Phytomedicine. 2024;126:155436. https:\/\/doi.org\/10.1016\/j.phymed.2024.155436.","journal-title":"Phytomedicine"},{"key":"4406_CR43","doi-asserted-by":"publisher","first-page":"1226962","DOI":"10.3389\/fimmu.2023.1226962","volume":"14","author":"Z Lin","year":"2023","unstructured":"Lin Z, Lv D, Liao X, Peng R, Liu H, Wu T, Wu K, Sun Y, Zhang Z. CircUBXN7 promotes macrophage infiltration and renal fibrosis associated with the IGF2BP2-dependent SP1 mRNA stability in diabetic kidney disease. Front Immunol. 2023;14:1226962. https:\/\/doi.org\/10.3389\/fimmu.2023.1226962.","journal-title":"Front Immunol"},{"key":"4406_CR44","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1158\/0008-5472.CAN-23-0783","volume":"83","author":"Y Fan","year":"2023","unstructured":"Fan Y, Song S, Li Y, Dhar SS, Jin J, Yoshimura K, Yao X, Wang R, Scott AW, Pizzi MP, et al. Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res. 2023;83:3726\u201338. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0783.","journal-title":"Cancer Res"},{"key":"4406_CR45","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.stem.2022.10.009","volume":"29","author":"E Porpiglia","year":"2022","unstructured":"Porpiglia E, Mai T, Kraft P, Holbrook CA, de Morree A, Gonzalez VD, Hilgendorf KI, Fresard L, Trejo A, Bhimaraju S, et al. Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration. Cell Stem Cell. 2022;29:1653\u2013e16681658. https:\/\/doi.org\/10.1016\/j.stem.2022.10.009.","journal-title":"Cell Stem Cell"},{"key":"4406_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162870","author":"Y Li","year":"2023","unstructured":"Li Y, Zhou H, Liu P, Lv D, Shi Y, Tang B, Xu J, Zhong T, Xu W, Zhang J, et al. SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47\/SIRPalpha axis. J Clin Invest 133. 2023. https:\/\/doi.org\/10.1172\/JCI162870.","journal-title":"J Clin Invest 133"},{"key":"4406_CR47","doi-asserted-by":"publisher","unstructured":"Dai P, Sun Y, Huang Z, Liu YT, Gao M, Liu HM, Shi J, He C, Xiang B, Yao Y, et al. USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity. Nat Commun 16. 2025;4564. https:\/\/doi.org\/10.1038\/s41467-025-59621-5.","DOI":"10.1038\/s41467-025-59621-5"},{"key":"4406_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004589","author":"A van Duijn","year":"2022","unstructured":"van Duijn A, Van der Burg SH, Scheeren FA. CD47\/SIRPalpha axis: bridging innate and adaptive immunity. J Immunother Cancer 10. 2022. https:\/\/doi.org\/10.1136\/jitc-2022-004589.","journal-title":"J Immunother Cancer 10"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04406-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04406-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04406-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:50:10Z","timestamp":1789689010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04406-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4406"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04406-z","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal protocols were approved by the Experimental Animal Welfare Ethics Committee of Central South University (APU-2025-0053).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"317"}}